Megan Sniecinski
CIK: 0001781480
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Praxis Precision Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 14, 2026PRAX
Praxis Precision Medicines, Inc.
Award(A)Direct89 shares at avg. $167.94$15K - Jan 12, 2026PRAX
Praxis Precision Medicines, Inc.
Tax Payment(F)Direct885 shares at avg. $275.74$244K - Jan 10, 2026PRAX
Praxis Precision Medicines, Inc.
Tax Payment(F)Direct1.1K shares at avg. $288.45$314K - Jan 8, 2026PRAX
Praxis Precision Medicines, Inc.
Award(A)Direct9.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | PRAX Praxis Precision Medicines, Inc. | Award(A) | 89 | $167.94 | $14,947 | Direct |
| Jan 12, 2026 | PRAX Praxis Precision Medicines, Inc. | Tax Payment(F) | 885 | $275.74 | $244,030 | Direct |
| Jan 10, 2026 | PRAX Praxis Precision Medicines, Inc. | Tax Payment(F) | 1,087 | $288.45 | $313,545 | Direct |
| Jan 8, 2026 | PRAX Praxis Precision Medicines, Inc. | Award(A) | 9,625 | - | $0 | Direct |
1-4 of 4 transactions
About Sniecinski Megan
Sniecinski Megan (SEC CIK 0001781480) files insider reports with the SEC as Chief Operating Officer of Praxis Precision Medicines, Inc. (PRAX).
Signal8 holds 4 ownership filings by Sniecinski Megan (1 Form 3, 3 Form 4), filed between Jan 9, 2026 and May 19, 2026. Those filings report 4 transactions, from Jan 8, 2026 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sniecinski Megan's filings is in BOSTON, MA.
Recent filings by Sniecinski Megan
Other insiders filing for Praxis Precision Medicines, Inc. (PRAX)
- Souza Marcio, Chief Executive Officer
- DeSimone Jill, Director
- Arbuckle Stuart A, Director
- Chodakewitz Jeffrey, Director
- YOUNG WILLIAM D, Director
- Cudkowicz Merit Ester, Director